0001816722-20-000001.txt : 20200709 0001816722-20-000001.hdr.sgml : 20200709 20200709130814 ACCESSION NUMBER: 0001816722-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200709 DATE AS OF CHANGE: 20200709 EFFECTIVENESS DATE: 20200709 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ansa Biotechnologies, Inc. CENTRAL INDEX KEY: 0001816722 IRS NUMBER: 830744780 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-370569 FILM NUMBER: 201020108 BUSINESS ADDRESS: STREET 1: 626 BANCROFT WAY STREET 2: SUITE A CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: (248) 227-5556 MAIL ADDRESS: STREET 1: 626 BANCROFT WAY STREET 2: SUITE A CITY: BERKELEY STATE: CA ZIP: 94710 D 1 primary_doc.xml X0708 D LIVE 0001816722 Ansa Biotechnologies, Inc. 626 BANCROFT WAY SUITE A BERKELEY CA CALIFORNIA 94710 (248) 227-5556 DELAWARE None None Corporation true 2018 Daniel Hillel Lin-Arlow 626 Bancroft Way, Suite A Berkeley CA CALIFORNIA 94710 Executive Officer Director Sebastian Palluk 626 Bancroft Way, Suite A Berkeley CA CALIFORNIA 94710 Executive Officer Director Biotechnology Decline to Disclose 06b false 2020-06-24 true true true true Series Seed-1 Pfd Stock, Series Seed-2 Prd Stock, Series Seed-3 Pfd Stock, Series Seed-4 Pfd Stock, Series Seed-5 Pfd Stock, and Simple Agreements for Future Equity ("SAFES") and the underlying shares of Common Stock issuable upon the conversion thereof. false 0 9213151 4734242 4478909 false 24 0 true 0 true 0 true false Ansa Biotechnologies, Inc. /s/ Dan Lin-Arlow Daniel Hillel Lin-Arlow Chief Executive Officer 2020-07-09